SCHEMBL10265606

SCHEMBL10265606

Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)c(CF)c2)cc1-c1cnc2cccnn12

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ABL1 P00519 17/20 0.64
▸ BCR P11274 3/20 0.62
▸ ABL2 P42684 2/20 0.60
▸ CYP3A4 P08684 2/20 0.60
▸ KCNH2 Q12809 2/20 0.60
▸ GAK O14976 1/20 0.60
▸ MLNR O43193 1/20 0.60
▸ RIPK2 O43353 1/20 0.60
▸ JAK2 O60674 1/20 0.60
▸ NR1I2 O75469 1/20 0.60
▸ ABCB11 O95342 1/20 0.60
▸ MAP4K4 O95819 1/20 0.60
▸ EGFR P00533 1/20 0.60
▸ NR3C1 P04150 1/20 0.60
▸ ERBB2 P04626 1/20 0.60
▸ NTRK1 P04629 1/20 0.60
▸ LCK P06239 1/20 0.60
▸ FYN P06241 1/20 0.60
▸ PGR P06401 1/20 0.60
▸ CSF1R P07333 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9610934 0.90 ABL1 (0.75) ABL1BCRABL2CYP3A4KCNH2
SCHEMBL9611050 0.89 ABL1 (0.74) ABL1BCRABL2CYP3A4KCNH2
SCHEMBL9610953 0.88 ABL1 (0.77) ABL1BCRABL2CYP3A4KCNH2
SCHEMBL9610974 0.87 ABL1 (0.75) ABL1BCRABL2CYP3A4KCNH2
SCHEMBL16644576 0.85 ABL1 (0.82) ABL1BCRABL2CYP3A4KCNH2
SCHEMBL15473029 0.84 ABL1 (0.83) ABL1BCRABL2CYP3A4KCNH2
SCHEMBL9610999 0.82 ABL1 (0.76) ABL1BCRABL2CYP3A4KCNH2
SCHEMBL10266091 0.82 ABL1 (0.68) ABL1BCRABL2CYP3A4KCNH2
SCHEMBL9610950 0.80 ABL1 (0.75) ABL1BCRABL2CYP3A4KCNH2
SCHEMBL22995915 0.79 ABL1 (0.88) ABL1BCRABL2CYP3A4KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8114874-B2 Substituted acetylenic imidazo[1,2-B]pyridazine compounds as kinase inhibitors ARIAD PHARMACEUTICALS, INC. (US) 2012-02-14 — — US disclosed
Send feedback